A Study of Continued Treatment Among Participants Who Have Responded to Peginterferon Alfa-2a (Pegasys®) or Recombinant Interferon Alfa-2a (Roferon-A®) in Prior Clinical Studies

Clinical trial NCT02829775 · COMPLETED

Trial details

NCT number: NCT02829775
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Chronic Myelogenous Leukemia Malignant Melanoma Renal Cell Carcinoma

Start date: 2004-01-01
Primary completion: 2008-01-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.